These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9135615)

  • 21. Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis.
    Ejaz AA; Zabaneh RI; Tiwari P; Nawab ZM; Leehey DJ; Ing TS
    Nephrol Dial Transplant; 1994; 9(10):1492-4. PubMed ID: 7816268
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypercalcemia and renal failure in the course of sarcoidosis].
    Kozielski J
    Pneumonol Alergol Pol; 2013; 81(2):182-3. PubMed ID: 23420435
    [No Abstract]   [Full Text] [Related]  

  • 25. Pamidronate use in two cases of hypercalcaemia secondary to hyperparathyroidism.
    Weatherall M
    N Z Med J; 1992 Sep; 105(942):389. PubMed ID: 1436854
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia.
    Haykal T; Sundus S; Bachuwa G; Danish R
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30674496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia.
    Nesković-Konstantinović Z; Mitrović L; Petrović J; Stamatović L; Ristović Z
    Support Care Cancer; 1995 Nov; 3(6):422-4. PubMed ID: 8564348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
    Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
    Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
    Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
    Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypercalcemia revealing sarcoidosis in a child].
    Kinné M; Filleron A; Salet R; Saumet L; Baron Joly S; Tran TA
    Arch Pediatr; 2016 May; 23(5):508-13. PubMed ID: 27021884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post partum presentation of hypercalcaemic sarcoidosis.
    Wilson-Holt N
    Postgrad Med J; 1985 Jul; 61(717):627-8. PubMed ID: 4022896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of immobilisation hypercalcaemia in acute intermittent porphyria: experience from three cases.
    Reading PJ; Newman PK; Kelly WF; Bateson MC; Rothwell P
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):421-2. PubMed ID: 9120470
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.
    Tan TT; Alzaid AA; Sutcliffe N; Gardner MD; Thomson JA; Boyle IT
    Postgrad Med J; 1988 Mar; 64(749):224-7. PubMed ID: 3174541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic high-dose pamidronate in refractory malignant hypercalcaemia.
    Judson I; Booth F; Gore M; McElwain T
    Lancet; 1990 Mar; 335(8692):802. PubMed ID: 1969552
    [No Abstract]   [Full Text] [Related]  

  • 36. An audit of the management of malignant hypercalcaemia.
    Gerrard GE; Dodwell DJ; Vail A; Watters J; Overend MA
    Clin Oncol (R Coll Radiol); 1996; 8(1):39-42. PubMed ID: 8688360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
    Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
    Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
    Czosnowski LM; Hudson JQ; Canada RB
    Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune reconstitution sarcoidosis presenting with hypercalcaemia and renal failure in HIV infection.
    Ferrand RA; Cartledge JD; Connolly J; Standish RA; Miller RF
    Int J STD AIDS; 2007 Feb; 18(2):138-9. PubMed ID: 17331293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypercalcaemia of malignancy.
    Heath DA
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.